Drug Law Weekly
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Drug Law Weekly
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Acute Lymphoblastic Leukemia
Researchers from Odense University, Department of Paediatrics publish new studies and findings in the area of acute lymphoblastic leukemia in children
June 26th, 2007
Data detailed in "Late cardiac effects of anthracycline containing therapy for childhood acute lymphoblastic leukemia" have been presented. According to a study from Odense, Denmark, "At present about 80% of children with acute lymphoblastic leukemia (ALL) will be cured following treatment with multi-drug chemotherapy. A major concern for this growing number of survivors is the risk of late effects of treatment." "The aim of this study was to determine whether signs of cardiomyopathy were present in patients treated in childhood with cumulative anthracycline doses of less than 300 mg/m2. PROCEDURE: Evaluation of cardiac function in a cohort of 63 long-term...
Source: Drug Law Weekly (2007-06-26)
|
